Choose a country to view content specific to your location
Choose a country to view content specific to your location
New Delhi metallo-β-lactamase (NDM) is an enzyme and readily transferable antibiotic resistance factor that can spread from one strain of bacteria to another by horizontal gene transfer. NDM confers enteric bacteria resistance to nearly all β-lactams, including carbapenems, which are a mainstay for the treatment of antibiotic-resistant bacterial infections. NDM-1 was initially identified from Klebsiella pneumoniae in 2008 and since then 17 new NDM alleles have been identified (NDM-1 to -17), with most of them originating from Asia. The variants arise from site mutations within the gene encoding the beta-lactamase. NDM-1 is the most common variant in cases of clinical infections. Accurately diagnosing NDM is crucial for effective treatment and preventing the spread of antibiotic-resistant bacteria.
Contact us to learn more about Meridian’s molecular or immunoassay reagent portfolio. We want to hear from you!
Have questions about a product? Want to learn more about Meridian’s molecular or immunoassay reagent portfolio? We want to hear from you!
By submitting your information in this form, you agree that your personal information may be stored and processed in any country where we have facilities or service providers, and by using our “Contact Us” page you agree to the transfer of information to countries outside of your country of residence, including to the United States, which may provide for different data protection rules than in your country. The information you submit will be governed by our Privacy Statement.
| Type |
|---|
| Format |
| Host/Source |
| Isotype |
| Tested Apps |
| Unit |
| Catalog |
| Buffer |
| Immunogen |
| COFA Description |
| COFA Notes |
| Recombination |
| SDS |
| COA |
| Product Information Sheet |
| Request Sample |
